Наркевич, И. А.
| Issue | Section | Title | Abstract | File |
| No 3 (2021) | Articles | A structural analysis of sales of drugs for the treatment of chronic hepatitis C in the Russian market | Abstract |
 (Rus) |
| No 3 (2021) | Articles | Russian marketing analysis of biologically active additives with pancreatic enzyme | Abstract |
(Rus) |
| No 7-8 (2020) | Articles | Analysis of current issues for development of pharmaceutical products export in the russian federation: the case of biotechnology enterprise | Abstract |
(Rus) |
| No 9 (2020) | Articles | Comparison and analysis of the fda approved orphane drugs register and the vital and essential drugs list of the Russian Federation | Abstract |
(Rus) |
| No 3 (2019) | Articles | Review of Federal medicine assistance schemes | Abstract |
(Rus) |
| No 7-8 (2019) | Articles | Analysis of the drug assortment for palliative care for children in the Russian Federation | Abstract |
(Rus) |
| No 9 (2019) | Articles | Development of the rare (orphan) drug market | Abstract |
(Rus) |
| No 10 (2019) | Articles | Analysis of the Russian paediatric antibacterials market | Abstract |
(Rus) |
| No 11 (2018) | Articles | Characterization of export prospect of domestic anti-influenza vaccines in Latin American countries and Carribeans | Abstract |
(Rus) |
| No 4 (2021) | Articles | Development of proposals for improving the processes of circulation of extemporal drugs and regulation of prescription and production activities of pharmaceutical organizations in the Russian Federation | Abstract |